The U.S. chiropractic market size was valued at USD 450.7 million in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 26.3% from 2023 to 2030. As a complementary treatment to pharmaceutical drugs, chiropractic care has seen a substantial increase in popularity. ... Read More »
December 2023The global pharmaceutical market size was estimated at USD 1,482.0 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.12% from 2023 to 2030. The pharmaceutical industry is witnessing growth due to factors such as the increasing chronic disease prevalence... Read More »
December 2023The global drug discovery informatics market size was valued at USD 2.96 billion in 2022 and is anticipated to grow at a CAGR of 11.2% from 2023 to 2030. The market for drug discovery informatics is expected to experience significant growth in the coming years. This can be attributed to ... Read More »
December 2023The global advanced therapy medicinal products market size was valued at USD 27.04 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 16.8% from 2023 to 2030. The emergence of Advanced Therapy Medicinal Products (ATMPs) has transformed the pharmaceutical i... Read More »
December 2023The global nicotine replacement therapy market size was valued at USD 59.4 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 16.3% from 2023 to 2030. The growth can be attributed to the growing number of technological advancements and the increasing nu... Read More »
November 2023The global acute repetitive seizures market size was estimated at USD 2.60 billion in 2022 and is expected to register a compound annual growth rate (CAGR) of 12.4% from 2023 to 2030. High unmet clinical needs for patients and caregivers, increased awareness of epilepsy, rising prevalenc... Read More »
November 2023The global bone and joint health supplements market size was estimated at USD 3.90 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 7.26% from 2024 to 2030. Factors such as rapidly growing geriatric population, prevalence of orthopedic disorders, and ris... Read More »
November 2023The global sodium hyaluronate-based products market size was valued at USD 9.83 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 7.7% from 2023 to 2030. The growth of the market can be attributed to an increase in the geriatric population, a demograph... Read More »
November 2023he global active pharmaceutical ingredients market size was estimated at USD 237.47 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.75% from 2024 to 2030. Advancements in Active Pharmaceutical Ingredient (API) manufacturing, growth of the biopharmaceu... Read More »
November 2023The global influenza vaccine market size was valued at USD 7.91 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 6.98% from 2024 to 2030. Vaccine sales are expected to increase throughout the forecast period due to an increase in incidence of seasonal fl... Read More »
November 2023The global vaccine adjuvants market size was valued at USD 1.62 billion in 2022 and is anticipated to grow at a CAGR of 2.3% from 2023 to 2030. The rising prevalence of cervical cancer, infectious diseases such as Human Papillomavirus (HPV), HIV, tuberculosis, etc., and other fatal disea... Read More »
November 2023The global peptide therapeutics market size was estimated at USD 43.45 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.1% from 2024 to 2030. The increasing prevalence of cancer and metabolic disorders such as osteoporosis, obesity, and diabetes is ex... Read More »
November 2023The global enteral feeding formulas market size was valued at USD 7.2 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2030. Increasing prevalence of chronic diseases, including cancer, stroke, multiple sclerosis, dementia, chronic liv... Read More »
November 2023The Missouri legal cannabis market size was estimated at USD 680 million in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 22.0% from 2024 to 2030. The growing disease burden of chronic pain and an increasing requirement for pain mana... Read More »
November 2023The global microbial API market size was estimated at USD 58.04 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.66% from 2023 to 2030. The growth of the market is attributed to the rising demand for biological drugs and the ease of their development u... Read More »
November 2023The Mexico hemp CBD market size was valued at USD 11.3 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 26.1% from 2023 to 2030. Favorable government policies that contributed to the increasing adoption of hemp-derived products and the growing acceptance... Read More »
October 2023The global hair growth supplement and treatment market size was estimated at USD 7.74 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 6.15% from 2024 to 2030. The market is witnessing a significant boost due to the increasing prevalence of hair loss dis... Read More »
October 2023The global myasthenia gravis treatment market size was valued at USD 2.01 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 9.0% from 2023 to 2030. The key factors driving this market include the rising adoption of immunotherapies, the approval of prom... Read More »
October 2023The global atopic dermatitis drugs market size was valued at USD 14.19 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 8.4% from 2023 to 2030. The growing prevalence of atopic dermatitis, strong pipeline, emergence of biologics, and untapped opportun... Read More »
October 2023The global idiopathic thrombocytopenic purpura therapeutics market size was valued at USD 622.6 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.0% from 2023 to 2030. The prevalence of idiopathic thrombocytopenic purpura (ITP) has been rising, leading ... Read More »
October 2023